Perrigo Finance Unlimited
Perrigo Finance Unlimited Company operates as the dedicated bond-issuing financing entity of Perrigo Company plc, an Irish-domiciled global consumer self-care company. The operating enterprise formulates, manufactures, and distributes over-the-counter (OTC) health products, store-brand infant formulas, oral care items, and skin care therapies. Main revenue drivers for the operating group comprise global commercial sales of retailer store-brand OTC medicines, infant nutrition products, and branded self-care remedies to retail store chains. Perrigo serves supermarket chains, mass merchandisers, retail pharmacies, and consumer shoppers across North America, Europe, and international markets. The enterprise holds a world-dominant market position as the largest manufacturer of retailer store-brand OTC pharmaceutical products in the world. Headquartered in Dublin, Ireland, Perrigo Finance Unlimited Company issues debt in capital markets.
5 of the funds FundTelligence covers report a position in Perrigo Finance Unlimited.
- Sector
- Health Care
- Country
- Ireland
- Funds holding it
- 5
Funds holding Perrigo Finance Unlimited
- Alfred Berg Global High Yield — Alfred Berg · 0.39 % (full portfolio disclosed, June 2026)
- JPM Europe High Yield Bond Fund — JPM · 0.24 % (full portfolio disclosed, June 2026)
- Nordea Global High Yield Enhanced Bond Fund — Nordea Funds · 0.16 % (full portfolio disclosed, September 2026)
- T. Rowe Price Global High Yield Bond Fund — T. Rowe Price · 0.14 % (full portfolio disclosed, September 2026)
- Mercer Global High Yield Bond Fund — Mercer · 0.1 % (full portfolio disclosed, December 2025)